They function by mimicking the action of GLP-1 hormone, which plays a crucial role in stimulating insulin secretion, inhibiting glucagon secretion, and delaying gastric emptying to suppress appetite, ...

The rise of GLP-1s (glucagon-like peptides) has revolutionized obesity management. These medications help people shed pounds ...

Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon ...

Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...

AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire global rights to GUB014295, a ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

When these hormones are activated, they slow stomach emptying and reduce glucagon secretion. Glucagon is a hormone involved in appetite and blood sugar regulation. This could help you to lose ...

In addition to impaired insulin secretion, type 2 diabetic patients also have elevated levels of glucagon, which worsens hyperglycemia by increasing glucose production by the liver. Type 2 ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

Liraglutide in United Kingdom: Our Bureau, Bengaluru Friday, February 28, 2025, 15:30 Hrs [IST] Biocon Limited, an innovation-led global ...